Lynch Regenerative Medicine Acquires REGRANEX® Gel and Exclusive Rights to Use Recombinant Pure PDGF for Soft Tissue Rejuvenation and Regeneration View Larger Image LRM Press Release Regranex Acquisition 3-31-25Download Sara Pruneski2025-04-03T10:46:13-06:00April 3rd, 2025|General, News| Share This On Your Favorite Platform! FacebookXRedditLinkedInTumblrPinterestEmail Related Posts Life Science Venture Program Educational Series: Knoxville Beer & Biotech: Knoxville Life Science Tennessee NIH Funding Letter 2025 State Policy Agenda LST Foundation Announces Newly Accepted Companies and Entrepreneurs-in-Residence for Life Science Venture Program
